Success Metrics

Clinical Success Rate

75.0%

Based on 6 completed trials

Completion Rate

75%(6/8)

Active Trials

2(17%)

Results Posted

33%(2 trials)

Terminated

2(17%)

Phase Distribution

Ph not_applicable

25%

Ph phase_3

Ph phase_2

42%

Ph phase_1

17%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution11 total trials

Phase 1Safety & dosage

2(18.2%)

Phase 2Efficacy & side effects

5(45.5%)

Phase 3Large-scale testing

1(9.1%)

N/ANon-phased studies

3(27.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(6)

Terminated(2)

Other(1)

Detailed Status

Completed6

Recruiting2

Terminated2

Suspended1

Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

75.0%

Most Advanced

Phase 3

Trials by Phase

Phase 12 (18.2%)

Phase 25 (45.5%)

Phase 31 (9.1%)

N/A3 (27.3%)

Trials by Status

suspended18%

recruiting217%

terminated217%

enrolling_by_invitation18%

completed650%

Recent Activity

2 active trials

Showing 5 of 12

recruitingphase_2

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

NCT06335888

enrolling_by_invitationphase_2

Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder

NCT05015881

suspendedphase_1

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

NCT02130492

terminatedphase_2

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer

NCT00794339

recruitingphase_1

Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging

NCT04275453

View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials

NCT06335888Phase 2

A Clinical Trial to Investigate 18F-AzaFol in the Diagnosis of Large Vessel Vasculitis

Recruiting

NCT05015881Phase 2

Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder

Enrolling By Invitation

NCT02130492Phase 1

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

Suspended

NCT00794339Phase 2

Phase II Trial of 64Cu-ATSM PET/CT in Cervical Cancer

Terminated

NCT04275453Phase 1

Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging

Recruiting

NCT02317393Phase 2

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy

Completed

NCT00424138Not Applicable

FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy

Terminated

NCT00963807Phase 2

A Comparison of FLT to FDG PET/CT in the Early Assessment of Chemotherapy Response in Stage IB-IIIA Resectable NSCLC

Completed

NCT00576563Not Applicable

Rectal Study: Value of Repeated FDG-PET-CT Scans in Rectal Cancer

Completed

NCT00767273Not Applicable

Investigate Role of Metabolic Imaging in Predicting Tumor Response/Outcome After Pancreatic CA Tx